Mesenchymal stem cells can be used for multiple purposes, some of which will prove enormously beneficial for different conditions and diseases. Therefore, we are glad to inform our readers that treating idiopathic pulmonary fibrosis, aka IPF, is easier today than ever before because of mesenchymal stem cells, which have shown a remarkable potential to help all those who suffer from this condition improve greatly.
Pulmonary fibrosis is only one of many other airway diseases, such as COPD or chronic bronchitis that can currently be successfully treated with stem cells. Having already delivered encouraging results, it is obvious to all that this technique of treating pulmonary conditions is still in its infancy and in due time, after more tests and clinical trials have been carried out, the improvements will be even more favourable to the many patients suffering from these harsh conditions.
The journal Respirology recently published an article regarding a study from the University of Pittsburgh School of Medicine, that was conducted in order to offer an insight into the potential improvements that mesenchymal stem cells have to offer when treating lung fibrosis. It was also underscored how a deeper comprehension of the cellular and molecular events linked to lung fibrosis will help any attempts to use mesenchymal stem cells to reverse the condition or to at least slow down its progression.
Unique Access Medical takes pride in offering results that live up to our most demanding patients and although other organisations offer treatments that deliver improvements, our outstanding professional team can offer a more improved version of the above-mentioned treatments, which would include, among others, higher quantities of mesenchymal stem cells, multiple injections and stem cell growth factors.
The promising study that the Pittsburg researchers carried out also underlined that, even if the anti-fibrotic effects of mesenchymal stem cell transplants can be found in lab mice and other animals, current clinical studies will be more helpful if they focused their time, efforts and attention on other endeavours, such as slowing down the progression of the disease, instead of reversing fibrosis itself, which is on its own a much harder and challenging goal to accomplish.
The same scientists claim that the use of mesenchymal stem cells can also be used with patients that suffer from acute exacerbations of their lung fibrosis. Optimally, stem cells will prevent the worsening effects of the rapid deterioration of acute states, which will translate as a higher life expectancy for many patients.
Unique Access Medical provides some of the finest and most propitious treatments available. Pulmonary fibrosis is not a foreign condition to us and we feel confident we will be able to help you. If you are interested in our stem cell treatments for this disease, please contact us and we will get back to you at your earliest convenience.